| Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study P Naaber, L Tserel, K Kangro, E Sepp, V Jürjenson, A Adamson, ... The Lancet Regional Health–Europe 10, 2021 | 616 | 2021 |
| Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 L Haljasmägi, A Salumets, AP Rumm, M Jürgenson, E Krassohhina, ... Scientific reports 10 (1), 20533, 2020 | 92 | 2020 |
| Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data P Naaber, K Hunt, J Pesukova, L Haljasmägi, P Rumm, P Peterson, ... PloS one 15 (10), e0237548, 2020 | 60 | 2020 |
| Epigenetic quantification of immunosenescent CD8+ TEMRA cells in human blood A Salumets, L Tserel, AP Rumm, L Türk, K Kingo, K Saks, A Oras, R Uibo, ... Aging cell 21 (5), e13607, 2022 | 39 | 2022 |
| LIPS method for the detection of SARS‐CoV‐2 antibodies to spike and nucleocapsid proteins L Haljasmägi, A Remm, AP Rumm, E Krassohhina, H Sein, A Tamm, ... European Journal of Immunology 50 (8), 1234-1236, 2020 | 33 | 2020 |
| Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers O Dufva, S Gandolfi, J Huuhtanen, O Dashevsky, H Duàn, K Saeed, ... Immunity 56 (12), 2816-2835. e13, 2023 | 25 | 2023 |
| Genomic Subtypes of AML Define Sensitivity to NK Cell Cytotoxicity H Duàn, E Jokinen, H Lähteenmäki, J Klievink, J Bouhlal, E Laajala, ... Blood 144 (Supplement 1), 329-329, 2024 | | 2024 |
| Primary Acute Myeloid Leukemia Cells Trigger Distinct Activation Patterns in Expanded NK Cells H Duàn, O Dufva, E Jokinen, H Lähteenmäki, J Klievink, J Bouhlal, ... Blood 142, 66, 2023 | | 2023 |
